
    
      The plan is to collect 200 samples (50 IBS' 50 Crohn's disease, 50 ulcerative colitis and 50
      controls). The patients included in the study will undergo an evaluation by a
      gastroenterologist after signing an informed consent and will answer a questionnaire.

      The samples will analyzed in the laboratory of Dr. Haick.
    
  